Should a new brand use private label or contract manufacturing?

Private label, in almost every case. Contract manufacturing carries development and validation cost that has to be amortised across volume a new brand does not have yet, and the formulation question is already settled by what the literature and the market support.

Who owns the formulation in a private label arrangement?

The supplier. You own your branding, pricing, customers and channel. That division is what makes the model work — and a supplier willing to let you claim you manufactured the material is signalling how they treat their other clients.

Supplier Evaluation·3 min read

White label, private label, contract manufacturing — the difference

Three terms used interchangeably that mean different things commercially. Which one you actually want depends on who owns the formulation and who carries the inventory.

White label means buying an existing product and putting your name on it. Private label usually means the same thing with more control over presentation. Contract manufacturing means paying someone to make a product you specify. The distinction that matters commercially is who owns the formulation and who carries the inventory risk.

By the Bench Grade Research Team · Last updated October 7, 2026

The three models, plainly

What each term actually describes
Model	Formulation	Inventory risk	Typical minimum
White label	Supplier's existing product	Usually the buyer's, bought forward	Moderate
Private label	Supplier's product, buyer controls presentation	Buyer's	Moderate
Contract manufacturing	Buyer specifies, supplier builds	Buyer's, plus development cost	High

In practice the peptide market uses white label and private label interchangeably, and both usually describe the same arrangement: an existing, already-validated preparation supplied under your branding. Contract manufacturing is genuinely different — you are commissioning something that does not yet exist, and paying for the development and validation that implies.

Why the distinction decides your minimum

A white or private label arrangement draws on inventory the supplier already makes, so the minimum reflects a commercially sensible first order rather than a production run. Contract manufacturing carries a setup cost that has to be amortised, which is why those minimums are higher and why the first order is rarely the cheapest one.

For most operators entering this category, private label is the correct model. The formulation question is already settled by the literature and by what the market buys; what is unsettled is your brand, your customers and your fulfillment.

What you are actually buying in a private label arrangement

A preparation already synthesised, filled, finished and tested, rather than a project.
Analytical documentation per lot, which is what your own customers will ask for.
Your labeling, your branding, and where offered, Certificates of Analysis re-issued in your name.
A fulfillment choice: take bulk to your own premises, or have the supplier ship individual orders under your brand.

Where control actually sits

Under any of these models the supplier controls formulation, manufacturing process and testing, and you control branding, pricing, customers and channel. That division is not a limitation of private label — it is the reason it works. A supplier who will let you alter analytical values or claim you manufactured the material is telling you something about how they treat their other clients.

Our program

Bench Grade Peptides operates a private label program: research-use-only lyophilized preparations, third-party tested per lot, supplied under your branding with three fulfillment models. Minimums are set per account and written into the price sheet you receive.

References

Primary literature for the compounds discussed above. Links open the record on PubMed.

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing Sikiric P, et al. Curr Pharm Des. 2018. PMID 29998800 → · summary
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration Chang CH, et al. J Appl Physiol. 2011. PMID 21030672 → · summary
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog Ionescu M, et al. J Clin Endocrinol Metab. 2006. PMID 17018654 → · summary
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults Teichman SL, et al. J Clin Endocrinol Metab. 2006. PMID 16352683 → · summary
Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat Cerovecki T, et al. J Orthop Res. 2010. PMID 20225319 → · summary
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat Novinscak T, et al. Surg Today. 2008. PMID 18668315 → · summary
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation Krivic A, et al. J Orthop Res. 2006. PMID 16583442 → · summary
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth Staresinic M, et al. J Orthop Res. 2003. PMID 14554208 → · summary

Primary sources

Frequently asked questions

What is the difference between white label and private label peptides?: In this market the two terms are used interchangeably and usually describe the same arrangement: an existing, already-validated preparation supplied under your branding. The meaningful distinction is against contract manufacturing, where you specify a product that does not yet exist.
Should a new brand use private label or contract manufacturing?: Private label, in almost every case. Contract manufacturing carries development and validation cost that has to be amortised across volume a new brand does not have yet, and the formulation question is already settled by what the literature and the market support.
Who owns the formulation in a private label arrangement?: The supplier. You own your branding, pricing, customers and channel. That division is what makes the model work — and a supplier willing to let you claim you manufactured the material is signalling how they treat their other clients.

Compounds discussed in this guide

Who publishes this guide

Who sells it: Bench Grade Peptides LLC, a US supplier of lyophilized synthetic peptides for laboratory research use only. It works with US manufacturing partners rather than running a facility of its own. Is Bench Grade Peptides legit? →
Certificates of Analysis: 139 third-party Certificates of Analysis covering 39 of 44 live products, published per lot in a public library anyone can read before ordering. A very recent lot can appear a few days after it enters the catalogue. COA library →
Ships from: Florida, by UPS, to US addresses only (no international shipping). The registered address in Dover, Delaware is the legal address only. Shipping →
Use: For laboratory research use only — not for human or veterinary use. Not a drug, supplement or medical device. Compliance and research use →

All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.